The Conversation (0)
- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Chart
Detailed Quote
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Featured Articles and Interviews
Press Releases
Jul 29, 2026
Merck Announces Fourth-Quarter 2026 Dividend
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.




